Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing Antituberculosis Therapy in Adults With Tuberculous Meningitis Based on N-Acetyltransferase Type 2 Genotyping

NCT03787940 is registered in ClinicalTrials.gov with Beijing Chest Hospital as lead sponsor.

NCT NCT03787940
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03787940 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing Antituberculosis Therapy in Adults With Tuberculous Meningitis Based on N-Acetyltransferase Type 2 Genotyping
Lead sponsor
Beijing Chest Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
March 4, 2019
Completion date
December 31, 2021
Enrollment
676 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculous meningitis